KRAS and non-small cell lung carcinoma: Lastly, LKB1 inactivation or mutation occurs in nearly 20% of NSCLC cases, and, similarly to KEAP1 mutations, occur concurrently with KRAS mutations in 7-10% of NSCLCs (60).